These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20545323)

  • 21. Conformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2.
    MacRaild CA; Zachrdla M; Andrew D; Krishnarjuna B; Nováček J; Žídek L; Sklenář V; Richards JS; Beeson JG; Anders RF; Norton RS
    PLoS One; 2015; 10(3):e0119899. PubMed ID: 25742002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
    Polhemus ME; Magill AJ; Cummings JF; Kester KE; Ockenhouse CF; Lanar DE; Dutta S; Barbosa A; Soisson L; Diggs CL; Robinson SA; Haynes JD; Stewart VA; Ware LA; Brando C; Krzych U; Bowden RA; Cohen JD; Dubois MC; Ofori-Anyinam O; De-Kock E; Ballou WR; Heppner DG
    Vaccine; 2007 May; 25(21):4203-12. PubMed ID: 17442466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid interactions of the malaria antigen merozoite surface protein 2.
    MacRaild CA; Pedersen MØ; Anders RF; Norton RS
    Biochim Biophys Acta; 2012 Nov; 1818(11):2572-8. PubMed ID: 22749949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate.
    Bonnet S; Pêtres S; Holm I; Fontaine T; Rosario S; Roth C; Longacre S
    Vaccine; 2006 Aug; 24(33-34):5997-6008. PubMed ID: 16814434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2.
    Das SC; Price JD; Gosling K; MacLennan N; Ataíde R; Seow J; Irani V; Atmosukarto II; Anders RF; Richards JS; MacRaild CA; Norton RS
    Vaccine; 2021 Mar; 39(12):1746-1757. PubMed ID: 33618946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.
    Zhang D; Pan W
    Infect Immun; 2005 Oct; 73(10):6530-6. PubMed ID: 16177327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
    Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
    Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation.
    Ferreira N; Saraiva MJ; Almeida MR
    FEBS Lett; 2011 Aug; 585(15):2424-30. PubMed ID: 21740906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1.
    James S; Moehle K; Renard A; Mueller MS; Vogel D; Zurbriggen R; Pluschke G; Robinson JA
    Chembiochem; 2006 Dec; 7(12):1943-50. PubMed ID: 17068840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens.
    Mahajan RC; Farooq U; Dubey ML; Malla N
    Indian J Pathol Microbiol; 2005 Oct; 48(4):429-38. PubMed ID: 16366089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular cloning and sequencing of genes encoding MSP2 isolates strains from two of Plasmodium falciparum from Chinese patients with cerebral malaria].
    Bian Z; Song G; Zheng Z
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):375-8. PubMed ID: 10923446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
    Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
    Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
    Xue X; Ding F; Zhang Q; Pan X; Qu L; Pan W
    Vaccine; 2010 Apr; 28(18):3152-8. PubMed ID: 20197139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (-)-epigallocatechin-3-gallate inhibits fibrillogenesis of chicken cystatin.
    Wang N; He J; Chang AK; Wang Y; Xu L; Chong X; Lu X; Sun Y; Xia X; Li H; Zhang B; Song Y; Kato A; Jones GW
    J Agric Food Chem; 2015 Feb; 63(5):1347-51. PubMed ID: 25620201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth.
    Bruder JT; Stefaniak ME; Patterson NB; Chen P; Konovalova S; Limbach K; Campo JJ; Ettyreddy D; Li S; Dubovsky F; Richie TL; King CR; Long CA; Doolan DL
    Vaccine; 2010 Apr; 28(18):3201-10. PubMed ID: 20188680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caught in action: mechanistic insights into antibody-mediated inhibition of Plasmodium merozoite invasion.
    Treeck M; Tamborrini M; Daubenberger CA; Gilberger TW; Voss TS
    Trends Parasitol; 2009 Nov; 25(11):494-7. PubMed ID: 19734093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the aggregation of an amyloidogenic sequence by flanking-disordered region in the intrinsically disordered antigen merozoite surface protein 2.
    Zhang W; Zhang J; MacRaild CA; Norton RS; Anders RF; Zhang X
    Eur Biophys J; 2019 Jan; 48(1):99-110. PubMed ID: 30443712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid interactions modulate the structural and antigenic properties of the C-terminal domain of the malaria antigen merozoite surface protein 2.
    Das SC; Morales RAV; Seow J; Krishnarjuna B; Dissanayake R; Anders RF; MacRaild CA; Norton RS
    FEBS J; 2017 Aug; 284(16):2649-2662. PubMed ID: 28618199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate.
    Morales RAV; MacRaild CA; Seow J; Krishnarjuna B; Drinkwater N; Rouet R; Anders RF; Christ D; McGowan S; Norton RS
    Sci Rep; 2015 May; 5():10103. PubMed ID: 25965408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.